Trials / Completed
CompletedNCT05934370
The Duke-Reinvestment Partners Community Collaborative (DRC)- Healthy Homes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 4 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this open-label, single arm home intervention feasibility study is to improve quality of life for children ages 4-16 years with asthma. The main questions it aims to answer are: * How can Home-Based Environmental Interventions (HEI) improve home air-quality problems in the home? * How can HEI improve asthma outcomes in children? Participants will be receiving HEI and completing asthma surveys.
Detailed description
All participants will receive an Intervention Kit, which could help with reducing environmental exposures. Participants will be monitored closely with up to 2 clinic visits, 2 home visits and up to 4 phone call visits. During the home visits, a study team will ask questions about your home and asthma, conduct home assessments, and provide training on use of the home kit. Participants may benefit from participation in this study through Home-Based Environmental Interventions by improving home air-quality and asthma outcomes. Study duration is approximately 24-30 weeks with 8 weeks of intervention, which includes baseline interview, questionnaires, spirometry testing, and participants receiving an Intervention Kit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Home-Based Environmental Interventions (HEI) | Housing Specialist will conduct an environmental home assessment to identify asthma triggers. • The participant will receive the following Breath Easy at Home Kit Products: * HEPA filtered upright vacuum cleaner * HEPA-filtered air purifier * Hypoallergenic latex free mattress and pillow covers * Healthier household cleaners * Non-toxic pest control devices for rodent control * Safe products to locate and kill roaches. |
Timeline
- Start date
- 2023-07-20
- Primary completion
- 2024-11-19
- Completion
- 2024-11-19
- First posted
- 2023-07-07
- Last updated
- 2024-12-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05934370. Inclusion in this directory is not an endorsement.